The NJ ACTS Pilot Program offers one-year pilot grants to foster collaborative research among faculty at Princeton University, New Jersey Institute of Technology (NJIT) and Rutgers University. It supports team research to promote novel approaches and methodologies in translational medicine and science, to foster interdisciplinary research to generate and/or test novel hypotheses, create partnerships that leverage in-kind partner support and to support high-risk/high-reward innovative projects. These projects are expected to provide key preliminary data for sustained extramural funding. View a list of all NJ ACTS Pilot Grants awarded.
2022 Pilot Program Letter of Intent Due May 6, Applications Due June 17
In 2022, the pilots grant program is seeking five categories of proposals:
- Translational and Clinical Sciences Award
- Methodological and Infrastructure Awards
- Propel Awards
- Valued Partnership Awards
- Improving Clinical and Translational Science through Process Innovation
To learn more, review the 2022 Pilot Programs Request for Applications.
Congratulations to the 2021 Awardees from Princeton - Alexander Ploss (MOL), Cameron Myhrvold (MOL), Nathaniel Daw (PNI), Celeste Nelson (CBE), Mohamed Donia (MOL), Sabine Petry (MOL), and Danelle Devenport (MOL).
Previous awardees from 2020 were Howard Stone (MAE), Andrea Graham (EEB), Jonathan Cohen (PNI), and Daniel Notterman (MOL).
The 2019 Pilot Program Awardees were Zemer Gitai (MOL), Esteban Engel (PNI), Catherine Peña (PNI), and Kathryn Edin (SOC/SPIA).
Pilot Grants Program 2021 is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation
Sign up for our interest list to receive updates and the latest information about the pilot grant program funding opportunity.